Jorgen Stenvik

St Olav's Hospital
Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Type 1 diabetes mellitus (T1DM) does not affect whole blood responses to alginate-based microspheres despite plasma lipid and glucose differences.

Type 1 diabetes mellitus (T1DM) does not affect whole blood responses to alginate-based microspheres despite plasma lipid and glucose differences.

Journal: Materials today. Bio

Published: May 08, 2025

A novel TIRAP-MyD88 inhibitor blocks TLR7- and TLR8-induced type I IFN responses.

A novel TIRAP-MyD88 inhibitor blocks TLR7- and TLR8-induced type I IFN responses.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 02, 2025

Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo.

Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo.

Journal: Life science alliance

Published: May 16, 2023

TIRAP/Mal Positively Regulates TLR8-Mediated Signaling via IRF5 in Human Cells.

TIRAP/Mal Positively Regulates TLR8-Mediated Signaling via IRF5 in Human Cells.

Journal: Biomedicines

Published: May 13, 2022

Nanoplastics affect the inflammatory cytokine release by primary human monocytes and dendritic cells.

Nanoplastics affect the inflammatory cytokine release by primary human monocytes and dendritic cells.

Journal: Environment international

Published: December 14, 2021

Modulating acrylic acid content of nanogels for drug delivery & biocompatibility studies.

Modulating acrylic acid content of nanogels for drug delivery & biocompatibility studies.

Journal: Journal of colloid and interface science

Published: May 26, 2021

GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections.

GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections.

Journal: The Journal of investigative dermatology

Published: November 04, 2020

TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria.

TLR8 and complement C5 induce cytokine release and thrombin activation in human whole blood challenged with Gram-positive bacteria.

Journal: Journal of leukocyte biology

Published: April 02, 2019

Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling.

Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling.

Journal: Frontiers in immunology

Published: February 28, 2019

Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

Journal: Molecular immunology

Published: November 27, 2018

Iron oxide nanoparticles enhance Toll-like receptor-induced cytokines in a particle size- and actin-dependent manner in human blood.

Iron oxide nanoparticles enhance Toll-like receptor-induced cytokines in a particle size- and actin-dependent manner in human blood.

Journal: Nanomedicine (London, England)

Published: August 08, 2018

Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages.

Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages.

Journal: Frontiers in immunology

Published: June 30, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026